Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

Obstetrics and Gynecology

Volumn 90, Issue 3, 1997, Pages 434-440

  Randall, Thomas C ^a   Kurman, Robert J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CONSERVATIVE TREATMENT; CONTRACEPTION; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING;

ADULT; AGE FACTORS; CARCINOMA; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; PREGNANCY; PROGESTINS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 0030797584     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00297-4     Document Type: Article

References (18)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. 1996. CA Cancer J Clin 1996;46:5-27.
2. Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial cancer in women 40 years of age or younger. Obstet Gynecol. 57:1981;699-704.
3. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol. 64:1984;417-421.
4. Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. Kurman RJ. Blaustein's pathology of the female genital tract. 4th ed. 1994;439-486 Springer-Verlag, New York.
5. Kurman RJ, Kaminski PE, Norris HJ. The behavior of endometrial hyperplasia A long term study of untreated hyperplasia in 170 patients . Cancer. 56:1985;403-412.
6. Wentz WB. Progestin therapy in endometrial hyperplasia. Gynecol Oncol. 2:1974;362-367.
7. Eichner E, Abellera M. Endometrial hyperplasia treated by progestagens. Obstet Gynecol. 38:1971;739-745.
8. Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progesten-treated endometrial hyperplasia. Am J Obstet Gynecol. 160:1989;126-131.
9. Deligdisch L. Effects of hormone therapy on the endometrium. Mod Pathol. 6:1993;94-106.
10. John HA, Cornes JS, Jackson WD, Bye P. Effect of a systemically administered progestogen on the histopathology of endometrial carcinoma. J Obstet Gynaecol Br Commonw. 8:1974;786-790.
11. Gerulath AH, Bonte R. Effect of progesterone on nucleic acid synthesis in vitro in carcinoma of the endometrium. Am J Obstet Gynecol. 128:1977;722-728.
12. Lewis GC, Slack NH, Mortel R, Bross IJ. Adjuvant progesterone therapy in the primary definitive treatment of endometrial carcinoma. Gynecol Oncol. 2:1974;368-373.
13. Holinka CF, Deligdisch L, Gurpide E. Histological evaluation of in vitro responses of endometrial adenocarcinoma to progestins and their relation to progesterone receptor levels. Cancer Res. 44:1984;293-295.
14. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol. 20:1985;139-155.
15. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer. 79:1997;320-327.
16. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium V. An analysis of prognosticators in patients with favorable subtypes and stage I disease . Cancer. 51:1983;1705-1709.
17. Gitsch G, Hanzal E, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 85:1995;504-508.
18. Vergote I, Kjorstad K, Abeler V, Kolstad P. A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer. 64:1989;1101-1106.